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T he paper by Concannon et al. in this issue of JGIMraises several thoughtful themes about the relationship
between researchers who study pragmatic health questions
and t h o s e i nd i v i du a l s—pa t i e n t s , c l i n i c i a n s ,
institutions—who use the study findings to make decisions
about their own health care or that of patients or
populations.1 As pointed out by the authors, meaningful
engagement of stakeholders in planning, conducting, and
disseminating research is thought to help make research
findings more “useful” and “used.” Engagement is intended
to help in making research questions more relevant and to
ensure that the research is conducted and the findings
interpreted with stakeholders’ viewpoints at the table.
Engagement may also serve to enhance recruitment of
study participants, and ultimately should lead to greater
uptake of research findings when the study is finished.
However, methods for establishing and maintain mean-
ingful engagement are not well-defined and may be
challenging. The frameworks developed by Concannon et
al. for categorizing types of stakeholders and stages of
research are useful starting points for developing and
evaluating engagement strategies. The descriptive informa-
tion in their report from published studies raises two
concerns worth mentioning. First, engagement of patients
was mentioned more frequently than engagement of
clinicians, and much more frequently than engagement of
payers and purchasers. While this could simply be an
artifact due to the authors’ mentioning patient engagement
more often because it seemed more novel, we suspect that it
is more representative of reality than not.
The Patient-Centered Outcomes Research Institute
(PCORI) has established itself on a foundation of ongoing,
meaningful engagement of all participants in the health care
system throughout the research cycle. Its Methodology
Standards2 recommend engagement and its funding an-
nouncements require it.
Because patients are the central focus of health care
delivery, it is logical that their wants, values, and challenges
are highly prioritized in studying health care choices.
Indeed, this principle is recognized around the world and
across multiple fields of clinical research, from international
efforts of the World Health Organization3 to drug develop-
ment research at the Food and Drug Administration in the
US.4
However, if other relevant stakeholder groups are not
also involved, we do not expect that the research would be
sufficiently representative of the stakeholders’ information
needs, environment, or priorities, therefore jeopardizing buy
in, practice changes and improved outcomes.
We would also emphasize our experience that the
dialogue of engagement should be multi-directional among
all stakeholder groups, rather than a series of bi-directional
discussions between each group and researchers. Placing
patient interests at the center, this dialogue allows diverse
groups to gain insight into the concerns and information
needs of others, and to shape research questions that are
mutually agreeable.
A second concern is the concentration of engagement
activities in the earlier stages of the research process, rather
than in the later stages of interpreting findings and
disseminating results. This is concerning, since the central
reason for engagement is to enhance dissemination and
uptake of relevant research findings. In some of the studies
reviewed, dissemination may not have been warranted, and
in others, researchers may simply not have attempted to
disseminate findings or chosen not to report on these
efforts. Nevertheless, this finding is also likely to reflect
reality, and emphasizes the need to engage with stakeholder
organizations, as well as with individuals, to further
dissemination.
An area of engagement emphasized by PCORI but not
included in the authors’ framework is the review of research
funding applications—not surprising because they focus on
engagement within research projects. Review of research
applications has traditionally been conducted by “peers,” by
“peers,” i.e., other researchers. PCORI has deliberately
introduced a “merit” review process to emphasize evalua-
tion of proposed research from several perspectives: that of
the scientist, but also those of patients and other relevant
stakeholders such as clinicians, businesses, private and
public payers, the life science industry, hospitals and health
systems, policymakers and training institutions, etc. Includ-
ing non-scientific reviewers in a traditionally scientific
discussion has presented challenges for all participants,Published online July 8, 2014
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but has also been called refreshing and rewarding in post-
review interviews and in a recent blog by a patient
reviewer.5 Despite the positive feedback from merit re-
viewers, the empirical evidence must be gathered to support
the anecdotal evidence that engaging non-scientists in peer
review results in more relevant studies. Data from the first
round of merit review suggest that all reviewers are
influenced by other perspectives during these face-to-face
discussions and that scores tend to converge on a somewhat
different set of top-scoring applications after discussion.6
Further evaluation (as described below) will determine if
these reviews lead to better, more useful studies.
The authors recognize the need for a “science of
engagement,” and have contributed to launching this
inquiry with frameworks and data collection tools. The
dramatic changes in the research process required by
PCORI call for careful study and evaluation of stakeholder
engagement. PCORI will routinely monitor data on a
number of outcomes that could reflect effects of engage-
ment.7 Outcomes include the usefulness of the funded
research questions and of completed studies, assessed
through pre-specified usefulness criteria and stakeholder
surveys; familiarity with and trust in PCORI-funded
research by patients and other stakeholders; participation
rates in research projects among eligible subjects and the
frequency of success in dissemination and implementation.
PCORI will also support research in this area by others
through our research methods funding announcement.
There is also a need to understand the mechanisms by
which engagement exerts beneficial impacts, if any. Of
particular interest to PCORI is the frequency with which
stakeholders influence the choice of the research questions,
comparators, or outcomes; and whether the partnerships of
researchers, patients, clinicians and other stakeholders
develop studies or recruitment practices that are more
attractive to potential participants. Finally, we are curious
to explore whether the participation and endorsement of
patients in research may influence institutional review
boards to weigh the potential benefits of these the research
more favorably in relationship to their typically low risk.
Perhaps most challenging, as suggested by the
Concannon et al. review, is achieving and sustaining true
engagement of stakeholders in the fabric of the research
study, from beginning to end. Most major funding organi-
zations do not currently require this type of prolonged and
relatively intense engagement. PCORI has recognized these
challenges and put several activities in motion to assist in
bridging possible gaps between researchers and stake-
holders. PCORI offers training for both researchers and
stakeholders, including a guide for engaging patients and
families in research; sample engagement plans; extensive
merit review training and post-merit review surveys to
better understand the challenges of diverse merit review
panels; and small competitive awards to allow researchers
and stakeholders to build relationships before an application
is developed and submitted.
Identifying the best practices in engagement, including
the amounts, timing and venues, remains a work in
progress. A key question requiring further study is that of
compensation for stakeholder participants. For some stake-
holders, this activity may be valued by their employer. For
others, the appropriate level of compensation is not settled,
although it certainly differs by the intensity of engagement.
For some vulnerable patient populations, monetary com-
pensation could in theory create a conflict for patients on
assistance programs. For some non-patient stakeholders,
potential conflicts of interest will need to be addressed.
In conclusion, it is encouraging that the Concannon et al.
review was able to document engagement in many aspects
of research. PCORI remains committed to promoting
intensive engagement of all appropriate stakeholders. The
gaps, challenges and unknowns provide a roadmap for
researchers and funding organizations to follow to make
sure that engagement becomes both robust and efficient.
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